-
Less bleeding by omitting aspirin in non-ST-segment elevation acute coronary syndrome patients: Rationale and design of the LEGACY study
van der Sangen, N. M. R., Kucuk, I. T., Sivanesan, S., Appelman, Y., ten Berg, J. M., Verburg, A., Azzahhafi, J., Arkenbout, E. K., Kikkert, W. J., Pisters, R., Jukema, J. W., Arslan, F., van ‘t Hof, A., Ilhan, M., Hoebers, L. P., van der Schaaf, R. J., Damman, P., Woudstra, P., van de Hoef, T. P., Anthonio, R. L., & 10 others , 1 Nov 2023, In: American Heart Journal. 265, p. 114-120 7 p.Research output: Contribution to journal › Article › Academic › peer-review
-
P2Y12-inhibitor monotherapy after coronary stenting: are all P2Y12-inhibitors equal?
van der Sangen, N. M. R., Kucuk, T. T., Beijk, M. A. M., ten Berg, J. M., Delewi, R., den Hartog, A. W., Appelman, Y., Verouden, N. J. W., Kikkert, W. J., Henriques, J. P. S., Claessen, B. E. PM. & Küçük, I. T., 2022, In: Expert Review of Cardiovascular Therapy. 20, 8, p. 637-645 9 p.Research output: Contribution to journal › Review article › Academic › peer-review
- All publications